Catherine Fourré

Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.

Pierre Laurent‐Puig, Richard Lubin, Sylvie Semhoun-Ducloux et al. · Gut · 1995 · 63 citations · Full text

Specific Markers, Pancreatic Cancer, Hepatology +15

SIMS MICROSCOPY: METHODOLOGY, PROBLEMS AND PERSPECTIVES IN MAPPING DRUGS AND NUCLEAR MEDICINE COMPOUNDS

Jérôme Clerc, Catherine Fourré, Philippe Fragu · Cell Biology International · 1997 · 58 citations

Engineering, Microscopy, Molecular Biology +24

Hereditary persistence of α-fetoprotein is due to both proximal and distal hepatocyte nuclear factor-1 site mutations 1 1The authors thank Dr. A. Chauchereau for the gift of A9TKCAT vector, Dr. O. Lahuna for helpful discussion, C. Aumas for excellent technical assistance, and S. Wenk for careful English proofreading of the text. We are grateful for the cooperation of the patients and their families.

Youssef Alj, Maria Georgiakaki, Jean‐François Savouret et al. · Gastroenterology · 2003 · 45 citations · Full text

Hepatology, Genetic Disorder, Genetics +12

SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.

Jérôme Clerc, Samuel E. Halpern, Catherine Fourré et al. · PubMed · 1993 · 28 citations

Mibg Diffusion, Engineering, Tumor Innervation +20

Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease

Catherine Buffet, Catherine Fourré, Claude Altman et al. · European Journal of Gastroenterology & Hepatology · 1996 · 15 citations